India's Pharmaceutical Exports

Country Profile

Belgium

Belgium is a major destination for Indian pharmaceutical exports — $516M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 71% of shipments, with vaccines contributing $203K. The compound annual growth rate since FY2015 stands at 12.2%.

🇧🇪 #11 Destination · $516M · 3.5× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$516M
Exports FY2025–26 DGCIS
3.5×
Growth FY2015→2026
1.7%
Share of India Total
#11
Rank Among 178 Markets
12.2%
CAGR FY2015→2026
Belgium is a major destination for Indian pharmaceutical exports — $516M in FY 2025–26, with 3.5× growth over the past decade. Medicines accounts for 71% of shipments, with vaccines contributing $203K. The compound annual growth rate since FY2015 stands at 12.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $368M (71.2%) Medicine Ingredients $134M (25.9%) Surgical & Hospital Supplies $13.6M (2.6%) Traditional & Herbal $1.40M (0.3%) Vaccines $203K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Belgium in the RBI overseas direct investment dataset (2011–2026).